Cervical Cancer

Researchers explored the intricate relationship between HIV infection in Ethiopian women and the development of precancerous cervical lesions, addressing existing inconsistencies in the literature, with the goal of determining the true impact of HIV on the risk of precancerous cervical lesions in this population. Some studies hint at a significant link between HIV and pre-cancerous...

The results of an MRI-based study show that patients with squamous cell cervical cancer with unclear tumor borders have a worse prognosis, lymph node metastases, and distant recurrence. One of the most common forms of cancer among women is cervical cancer. About 10,000 Japanese women are diagnosed with cervical cancer annually, and approximately 3,000 will...

Medically reviewed by Dr. Kimberly Langdon Cull, M.D. on Sept. 21, 2023 Chemoradiotherapy with concomitant nivolumab was found to be safe and effective for improving progression-free survival rates in cervical cancer. Concurrent chemoradiotherapy (CRT) improves immune-mediated tumor control by increasing phagocytosis and antigen presentation. The NiCOL phase I trial, conducted by Rodrigues et al., aimed to...

A recent study explores the barriers to breast and cervical cancer screening and potential interventions to increase participation among women in opioid substitution treatment, shedding light on the unique challenges these women face in accessing regular breast and cervical cancer screenings. Women with current or past drug use are at greater risk of poor outcomes...

Increased screening uptake is observed with mailed self-sampling kits by all sub-groups. Differences in effectiveness according to patient characteristics highlight opportunities to optimize self-sampling for priority groups. Human papillomavirus (HPV)-only is a cervical cancer screening method that is more sensitive than Papanicolaou (Pap) cytology-based testing. It has the further advantage of allowing individuals to collect...

Mailing human papillomavirus self-sampling kits to eligible women is a cost-effective method to improve screening rates for cervical cancer in the US healthcare system. Cervical cancer is largely preventable through early screening for precancerous changes caused by human papillomavirus (HPV). The currently available method for HPV-only (primary HPV screening) is more sensitive than the standard...

Age and race disparities in cervical cancer diagnosis and treatment were found to be significant for both adenocarcinoma and squamous cell carcinoma between 2004 and 2017. Among patients with cancer of the cervix, there are differences in treatment, diagnosis, and overall outcomes for patients with adenocarcinoma of the cervix (AC) compared to those with squamous...

Abdominal radical hysterectomy (ARH) is superior to radiochemotherapy (R-CT) in patients diagnosed with stage IB3 cervical cancer, according to the FIGO 2018 staging system, based on higher DFS and 5-year OS rates. Cervical cancer is a prevalent malignant condition of the genital tract of the female. It is the leading cause of death across the...

Socioeconomic factors are linked to disparities in HPV awareness and cervical cancer screening adherence. Cervical cancer is the 4th most common cancer in women worldwide and the 7th most common cancer overall. Family caregivers are at a greater risk of developing cervical cancer, depression, and other chronic conditions. However, despite their increased vulnerability, their knowledge...